|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits with other banks | ||||||||||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||||||||||
| Loans and leases | ||||||||||||||||||||
| Less: Unearned income | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Net loans and leases | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other identifiable intangibles | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Demand: Noninterest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Other time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under agreement to repurchase | ||||||||||||||||||||
| Short term borrowings | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Junior subordinated debt securities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, $2.50 par value per share Authorized - 500,000,000 shares; Issued - 90,329,896, 93,696,687 and 94,074,740 shares, respectively | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
